10-Q: Streamex Corp. Q1 2026 Financial Results and Update

Streamex Corp. reports Q1 2026 financial results, highlighting the successful repayment of convertible debt and the expansion of its digital asset infrastructure.

Summary

• Reported a net loss of $46.7 million for the first quarter of 2026, compared to a $2.8 million loss in the same period of 2025.
• Operating expenses rose significantly to $35.7 million, driven largely by $25.4 million in stock-based compensation.
• Successfully eliminated $50 million in convertible debt through a combination of cash repayment and equity conversion.
• Strengthened liquidity with $37.2 million in net proceeds from a January 2026 underwritten public offering.
• Consolidated Streamex Ltd. as a variable interest entity, holding $15.2 million in gold bullion to support the GLDY Token program.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral-to-cautious report; while the company successfully cleaned up its balance sheet by retiring toxic convertible debt, the massive net loss and ongoing internal control weaknesses present significant execution risks.

Positives

• Successfully retired all outstanding secured convertible debentures, removing significant debt overhang and associated security interests.
• Strengthened cash position through a $37.2 million underwritten public offering.
• Realized a $2.9 million gain from the sale of gold bullion assets.
• Transitioned to a new leadership team and appointed a new Chief Financial Officer to address internal control weaknesses.

Negatives

• Reported a substantial net loss of $46.7 million for the quarter.
• General and administrative expenses increased by over 1,000% year-over-year, primarily due to high stock-based compensation.
• Continued material weaknesses in internal control over financial reporting remain unresolved.
• The company's core digital asset and medical device businesses have yet to generate material revenue.

Risks

• Ongoing material weaknesses in internal control over financial reporting could impact the reliability of financial disclosures.
• The company remains in the development stage for its digital asset platform, with no guarantee of future commercial success or material revenue.
• Future capital requirements are uncertain and may necessitate further dilutive equity or debt financing.
• Legal proceedings, including a civil claim filed by a former advisor, could result in unforeseen liabilities.
• Dependence on the successful adoption of the GLDY Token program and the PURE EP platform.

Future Outlook

The company expects to continue incurring operating losses and negative cash flows until its digital asset infrastructure and PURE EP platform achieve sustained commercial success. Management plans to focus on platform maturity, regulatory compliance, and strategic partnerships to drive future revenue.

Management Comments

• Management believes the company has sufficient liquidity to continue as a going concern for at least one year.
• The company is actively working to remediate identified material weaknesses in internal control over financial reporting.

Industry Context

StockSavvy.ai notes that Streamex Corp. is attempting a pivot from a legacy medical device company to a digital asset infrastructure provider, a transition that involves significant cash burn and regulatory complexity common in the emerging RWA tokenization sector.

Comparison to Industry Standards

• The company's high reliance on stock-based compensation is aggressive compared to established technology firms.
• The shift toward tokenized real-world assets aligns with broader industry trends in blockchain-based finance, though the company remains in the early development stage compared to established fintech competitors.

Management Changes

Corporate Governance

Legal Proceedings

• A former advisor filed a Notice of Civil Claim in the Supreme Court of British Columbia alleging breach of contract and other claims; the company is defending the matter.

Related Party Transactions

• Two officers subscribed for GLDY Tokens on the same terms as the company.
• Accounts payable includes $907,000 due to related parties for compensation and reimbursements.

Stakeholder Impact

• Shareholders face potential dilution from future equity-based compensation and potential capital raises.
• Creditors have seen the removal of secured debt, improving the company's balance sheet structure.

Next Steps

• Continue remediation of material weaknesses in internal control over financial reporting.
• Advance commercialization of the Streamex Exchange platform and GLDY Token program.
• Evaluate strategic alternatives for legacy subsidiaries ViralClear and BioSig AI.

Key Dates

Recommendation

The company is in a high-risk transition phase. While the removal of convertible debt is a positive step, the lack of material revenue and ongoing internal control issues suggest a 'hold' until the company demonstrates a clear path to commercial viability.

Keywords

Streamex Corp, STEX, tokenization, digital assets, GLDY, biomedical technology, 10-Q, financial results